Microbot Medical (MBOT)
(Delayed Data from NSDQ)
$3.34 USD
-0.08 (-2.34%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $3.35 +0.01 (0.30%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MBOT 3.34 -0.08(-2.34%)
Will MBOT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MBOT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MBOT
Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market
MBOT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?
Beat the Market the Zacks Way: Ryanair, Monster Beverage, Ulta Beauty in Focus
MBOT Stock Gains Following FDA Submission of the LIBERTY System
Other News for MBOT
Is MBOT building bearish momentum? Fell Below 20 Day Moving Average shows up after plummeting 15.56%
Microbot Medical Secures $25.2M in New Funding Round
Microbot Medical announces exercise of outstanding preferred investment options
Microbot Medical announces exercise of outstanding preferred investment options
NR7 appears for MBOT after 4.11% move